What is Flu A?
Flu A is a kind of respiratory diseases caused by virus, it spreads rapidly and will cause severe harm to public health. In order to decrease the harm caused by Flu A, we should take the measures below:
Strengthen publicity and education
Improve public awareness, Strengthen publicity and education:
Promoting the education in the fields of transmission routes, symptoms, and preventive measures of Flu A, promote public's awareness of hygiene and self-protection, encourage people to pay attention to personal hygiene in daily life to reduce the chance of virus transmission. Encourage healthy eating, regular exercise, and adequate sleep to enhance individual immunity.
Precautions
Promote influenza vaccination and increase vaccination rates. Get influenza vaccination regularly every year, giving priority to protecting high-risk groups including children, the elderly, patients with chronic diseases, pregnant women, medical workers, etc.
Improve environmental hygiene management
Increase the ventilation rate in public places, and regularly disinfect schools, office buildings, transportation and other public places. In addition, reduce large gatherings during the peak influenza season. What's more, scenarios like public transportation, public places, schools, hospitals and other public places should be disinfected and cleaned to reduce the chance and harm of virus transmission.
Strong surveillance and epidemiological investigation
Strengthen the monitoring and epidemiological investigation of influenza A, promptly detect and diagnose cases, isolate and treat them in a timely manner, and prevent the spread and harm caused by the transmission of the virus. If necessary, the relative test kits can be applied for the detection of Flu A antigen.
For example, Singclean FLU A/B Antigen Test Kit (Colloidal Gold) is used for in vitro qualitative detection of influenza A/B antigen in human nasopharyngeal swab samples. Singclean COVID-19 & FLU A/B Antigen Test Kit (Colloidal Gold) is used for in vitro qualitative detection of 2019 Novel Coronavirus antigen and influenza A/B antigen in human nasopharyngeal swab samples. Singclean Respiratory Multiple Rapid Test Kit (Immunochromatography) is used for in vitro qualitative detection of influenza A/B antigen and other antigen (including COVID-19, Respiratory Syncytial Virus, Adenovirus and MP) in human nasopharyngeal swab samples.
Be used in a wide range of industries.
Conclusion
In short, in the process of reducing the harm of influenza A, we should strengthen publicity and education, strengthen monitoring and epidemiological investigation, comprehensively strengthen health protection and medical security, so as to minimize the harm of influenza A and protect the health of the people. Through comprehensive measures with prevention as the main measure, monitoring as the auxiliary measure, and treatment and education as the equal measure, the harm of influenza A to public health can be effectively reduced.